Study: Expedited breakthrough drug approvals linked to higher safety risks
January 12, 2026
January 12, 2026
CHAMPAIGN, Illinois, Jan. 12 -- The University of Illinois Urbana-Champaign campus issued the following news:
* * *
Study: Expedited breakthrough drug approvals linked to higher safety risks
*
CHAMPAIGN, Ill. -A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved under the U.S. Food and Drug Administration's "Breakthrough Therapy Designation" -a program desig . . .
* * *
Study: Expedited breakthrough drug approvals linked to higher safety risks
*
CHAMPAIGN, Ill. -A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved under the U.S. Food and Drug Administration's "Breakthrough Therapy Designation" -a program desig . . .